Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-31 @ 3:55 AM
Study NCT ID:
NCT05060003
Status:
TERMINATED
Last Update Posted:
2024-02-20
First Post:
2021-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-16
First Submit QC Date:
None
Study First Post Date:
2021-09-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-18
Results First Submit QC Date:
None
Results First Post Date:
2024-02-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-14
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL